In contrast, no significant association with CYP19A1 expression was found in analyses of the tumor type, size, stage, and grade, as well as for lymph node status, p53-, PR-, HER2-status, and the molecular subtype (Fig. 3c–g, i–l), consistent with previous reports [13, 15, 19, 47–50]. The gene discussed is CYP19A1; the disease is neoplasm.